aTyr Pharma, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ATYR Nasdaq 2834 atyrpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for aTyr Pharma, Inc.

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference - Nov 10th, 2025 6:00 am
Atyr Pharma: Q3 Earnings Snapshot - Nov 6th, 2025 2:48 pm
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update - Nov 6th, 2025 2:01 pm
Independent Director of aTyr Pharma Paul Schimmel Buys 91% More Shares - Oct 12th, 2025 6:31 am
aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025 - Sep 30th, 2025 3:30 am
Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma’s Phase 3 Clinical Trial Results - Sep 17th, 2025 8:01 am
Assessing aTyr Pharma (ATYR) Valuation as Investors Weigh Recent Stock Swings and Future Prospects - Sep 17th, 2025 6:14 am
aTyr Pharma stock crashes on Phase III pulmonary sarcoidosis fail - Sep 16th, 2025 5:20 am
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; aTyr Pharma, Oracle to Advance - Sep 16th, 2025 4:38 am
Sector Update: Health Care Stocks Decline Late Afternoon - Sep 15th, 2025 1:40 pm
Sector Update: Health Care Stocks Advance Premarket Monday - Sep 15th, 2025 7:17 am
ATyr shares plunge on trial miss in inflammatory lung disease - Sep 15th, 2025 6:11 am
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis - Sep 15th, 2025 5:30 am
1 Small-Cap Biotech Stock Poised for a Breakout - Sep 11th, 2025 8:15 am
Lead Therapy Trial Fuels aTyr Pharma’s (ATYR) Promising Upside, Leerink Stays Bullish - Sep 11th, 2025 1:31 am
Jefferies Raises Price Target for aTyr Pharma (ATYR) Ahead of Study Results - Sep 7th, 2025 10:30 pm
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 5th, 2025 2:00 pm
2 Small-Cap Biotech Stocks Well Positioned for a Breakout - Aug 27th, 2025 1:32 am
ATyr Pharma Rated as Overweight at Cantor Fitzgerald on Efzofitimod Expectations - Aug 19th, 2025 10:22 pm
High Growth US Tech Stocks To Watch In August 2025 - Aug 19th, 2025 11:38 am